Yu‐Shan Cheng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation”.

Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation

Frontiers in Microbiology(2020)10.3389/fmicb.2020.598203

N/A

0DataRank · unranked

67 citations

Kirill Gorshkov, Emily M. Lee, Miao Xu, Yu‐Shan Cheng, Nuo Sun +7 more

Four induced pluripotent stem cell lines (TRNDi021-C, TRNDi023-D, TRNDi024-D and TRNDi025-A) generated from fibroblasts of four healthy individuals

Stem Cell Research(2020)10.1016/j.scr.2020.102011

N/A

0DataRank · unranked

3 citations

Manisha Pradhan, Miao Xu, Yu‐Shan Cheng, Jeanette Beers, Kaari L. Linask +4 more

Drug combination therapy for emerging viral diseases

Drug Discovery Today(2021)10.1016/j.drudis.2021.05.008

N/A

0DataRank · unranked

179 citations

Yu‐Shan Cheng, Donald C. Lo, Wei Zheng, Zeenat A. Shyr

Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells

Experimental Cell Research(2021)10.1016/j.yexcr.2021.112785

N/A

0DataRank · unranked

11 citations

Yu‐Shan Cheng, Shu Yang, Manju Swaroop, Miao Xu, Wenwei Huang +2 more

Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1

Stem Cell Research(2021)10.1016/j.scr.2021.102447

N/A

0DataRank · unranked

4 citations

Manisha Pradhan, Yu‐Shan Cheng, Kirill Gorshkov, Atena Farkhondeh, Catherine Z. Chen +6 more

Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11

Stem Cell Research(2021)10.1016/j.scr.2021.102366

N/A

0DataRank · unranked

3 citations

Yu‐Shan Cheng, Miao Xu, Atena Farkhondeh, Jeanette Beers, Jizhong Zou +5 more

Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9

Stem Cell Research(2021)10.1016/j.scr.2021.102554

N/A

0DataRank · unranked

3 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene

Stem Cell Research(2021)10.1016/j.scr.2021.102400

N/A

0DataRank · unranked

1 citations

Atena Farkhondeh, Yu‐Shan Cheng, Miao Xu, Jeanette Beers, Jizhong Zou +6 more

Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1

Stem Cell Research(2021)10.1016/j.scr.2021.102387

N/A

0DataRank · unranked

2 citations

Charles D. Yeh, Jeanette Beers, Chengyu Liu, Yu‐Shan Cheng, Kirill Gorshkov +4 more

Inhibiting SARS‐CoV‐2 infection with lysosomal alkalizers

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02122

N/A

0DataRank · unranked

0 citations

Catherine Chen, Robert Bostwick, Lynn Rasmussen, Bruce Nguyen Tran, Yu‐Shan Cheng +21 more

Corrigendum to “Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9” [Stem Cell Res. 56 (2021) 102554]

Stem Cell Research(2021)10.1016/j.scr.2021.102602

N/A

0DataRank · unranked

0 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II

Experimental Cell Research(2022)10.1016/j.yexcr.2021.113007

N/A

0DataRank · unranked

17 citations

Yu‐Shan Cheng, Shu Yang, Manju Swaroop, Miao Xu, Jeanette Beers +6 more

Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells via an inhibition of CaMKII/CREB1 mediated ABCB1 expression

Frontiers in Oncology(2022)10.3389/fonc.2022.1068443

N/A

0DataRank · unranked

9 citations

Shu Yang, Yu‐Shan Cheng, Ni Sima, Wei Sun, Min Shen +4 more

A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction

Current Protocols(2023)10.1002/cpz1.866

N/A

0DataRank · unranked

15 citations

Miao Xu, Guibin Chen, Jeanette Beers, Catherine Z. Chen, Chengyu Liu +3 more

Corrigendum to “iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II” [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007]

Experimental Cell Research(2023)10.1016/j.yexcr.2023.113808

N/A

0DataRank · unranked

0 citations

Yu‐Shan Cheng, Shu Yang, Manju Swaroop, Miao Xu, Jeanette Beers +6 more